WR
WOODGRIFT RANDEL WILLIAM
Other
Insider track record
OtherAcross 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by WOODGRIFT RANDEL WILLIAM. Officer active across 1 company, notably Abbott Laboratories. In total, 8 disclosures have been logged. History available since 3 September 2021. The latest transaction was filed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations8 total
4,123 shares@ US$99.7719.0% of flowCommon shares without par valueSEC:0001415889-23-003926:0
9,504 shares0Common shares without par valueSEC:0001415889-23-003077:0
24,000 shares@ US$44.400.0005% mcap60.6% of flowCommon shares without par valueSEC:0001415889-22-004697:0
1,369 shares@ US$118.360.0001% mcap8.8% of flowCommon shares without par valueSEC:0001415889-22-003847:0
4,038 shares@ US$122.410.0002% mcap26.7% of flowCommon shares without par valueSEC:0001415889-22-002206:0
10,482 shares0Common shares without par valueSEC:0001415889-22-001750:0
1,000 shares@ US$38.400.0000% mcap2.0% of flowCommon shares without par valueSEC:0001415889-21-004285:0
1,000 shares@ US$38.401.6% of flowCommon shares without par valueSEC:0001415889-21-004285
About WOODGRIFT RANDEL WILLIAM
WOODGRIFT RANDEL WILLIAM is a director at Abbott Laboratories.